Literature DB >> 3519244

Effect of an alpha-glucosidase inhibitor (BAY m 1099) on post-prandial blood glucose and insulin in type II diabetics.

P H Joubert, W J Bam, N Manyane.   

Abstract

The effect of a new alpha-glucosidase inhibitor (BAY m 1099), a 1-deoxynojirimycin derivative, was studied in 10 black patients with Type II diabetes mellitus. It produced significant lowering of blood glucose concentration after standardized maize porridge meals. No significant untoward effects were noted. BAY m 1099 appears to offer potential benefit in the management of Type II diabetics, and more extensive clinical investigation is warranted.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519244     DOI: 10.1007/bf00614315

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  3 in total

1.  [Glucosidase inhibitors from Bacilli].

Authors:  D D Schmidt; W Frommer; L Müller; E Truscheit
Journal:  Naturwissenschaften       Date:  1979-11

2.  The effect of a 1-deoxynojirimycin derivative on post-prandial blood glucose and insulin levels in healthy black and white volunteers.

Authors:  P H Joubert; C P Venter; H F Joubert; I Hillebrand
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Inhibition of N-linked complex oligosaccharide formation by 1-deoxynojirimycin, an inhibitor of processing glucosidases.

Authors:  B Saunier; R D Kilker; J S Tkacz; A Quaroni; A Herscovics
Journal:  J Biol Chem       Date:  1982-12-10       Impact factor: 5.157

  3 in total
  4 in total

Review 1.  Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus.

Authors:  L J Scott; C M Spencer
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

2.  The effect of two new glucosidase inhibitors on blood glucose in healthy volunteers and in type II diabetics.

Authors:  K F Federlin; L Mehlburger; I Hillebrand; H Laube
Journal:  Acta Diabetol Lat       Date:  1987 Jul-Sep

3.  Investigation on the Enzymatic Profile of Mulberry Alkaloids by Enzymatic Study and Molecular Docking.

Authors:  Zhihua Liu; Ying Yang; Wujun Dong; Quan Liu; Renyun Wang; Jianmei Pang; Xuejun Xia; Xiangyang Zhu; Shuainan Liu; Zhufang Shen; Zhiyan Xiao; Yuling Liu
Journal:  Molecules       Date:  2019-05-08       Impact factor: 4.411

4.  Loss of cytomegalovirus infectivity after treatment with castanospermine or related plant alkaloids correlates with aberrant glycoprotein synthesis.

Authors:  D L Taylor; L E Fellows; G H Farrar; R J Nash; D Taylor-Robinson; M A Mobberley; T A Ryder; D J Jeffries; A S Tyms
Journal:  Antiviral Res       Date:  1988-11       Impact factor: 5.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.